These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7769832)

  • 1. Progenitor cells in the blood and marrow of patients with chronic phase chronic myeloid leukaemia respond differently to macrophage inflammatory protein-1 alpha.
    Nirsimloo N; Gordon MY
    Leuk Res; 1995 May; 19(5):319-23. PubMed ID: 7769832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contrasting effects of rh-MIP-1 alpha and TGF-beta 1 on chronic myeloid leukemia progenitors in vitro.
    Holyoake TL; Freshney MG; Sproul AM; Richmond LJ; Alcorn MJ; Steward WP; Fitzsimons E; Dunlop DJ; Franklin IM; Pragnell IB
    Stem Cells; 1993 Oct; 11 Suppl 3():122-8. PubMed ID: 8298472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unresponsiveness of primitive chronic myeloid leukemia cells to macrophage inflammatory protein 1 alpha, an inhibitor of primitive normal hematopoietic cells.
    Eaves CJ; Cashman JD; Wolpe SD; Eaves AC
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):12015-9. PubMed ID: 8265663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The tetrapeptide AcSDKP specifically blocks the cycling of primitive normal but not leukemic progenitors in long-term culture: evidence for an indirect mechanism.
    Cashman JD; Eaves AC; Eaves CJ
    Blood; 1994 Sep; 84(5):1534-42. PubMed ID: 8068944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of the human macrophage inflammatory protein family of cytokines (chemokines) on proliferation of human myeloid progenitor cells. Interacting effects involving suppression, synergistic suppression, and blocking of suppression.
    Broxmeyer HE; Sherry B; Cooper S; Lu L; Maze R; Beckmann MP; Cerami A; Ralph P
    J Immunol; 1993 Apr; 150(8 Pt 1):3448-58. PubMed ID: 7682242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage inflammatory protein (MIP)-1 beta abrogates the capacity of MIP-1 alpha to suppress myeloid progenitor cell growth.
    Broxmeyer HE; Sherry B; Cooper S; Ruscetti FW; Williams DE; Arosio P; Kwon BS; Cerami A
    J Immunol; 1991 Oct; 147(8):2586-94. PubMed ID: 1918979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of acute myelogenous leukemia progenitor proliferation by macrophage inflammatory protein 1-alpha.
    Ferrajoli A; Talpaz M; Zipf TF; Hirsch-Ginsberg C; Estey E; Wolpe SD; Estrov Z
    Leukemia; 1994 May; 8(5):798-805. PubMed ID: 8182937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of "discordant maturation' in chronic myeloid leukaemia using cultures of primitive progenitor cells and their production of clonogenic progeny (CFU-GM).
    Marley SB; Lewis JL; Scott MA; Goldman JM; Gordon MY
    Br J Haematol; 1996 Nov; 95(2):299-305. PubMed ID: 8904885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage inflammatory protein-1 alpha receptors are present on cells enriched for CD34 expression from patients with chronic myeloid leukemia.
    Chasty RC; Lucas GS; Owen-Lynch PJ; Pierce A; Whetton AD
    Blood; 1995 Dec; 86(11):4270-7. PubMed ID: 7492787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tyrosine kinase inhibitor STI571, like interferon-alpha, preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors from patients with chronic myeloid leukemia.
    Marley SB; Deininger MW; Davidson RJ; Goldman JM; Gordon MY
    Exp Hematol; 2000 May; 28(5):551-7. PubMed ID: 10812245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the hemoregulatory peptide (pEEDCK)2 (pyroGlu-Glu-Asp-Cys-Lys)2 and MIP-1alpha is reduced in bone marrow cultures from patients with chronic myeloid leukemia (CML).
    Karlic H; Louda N; Pfeilstöcker M; Keil F; Lohninger A; Pittermann E; Paukovits J
    Stem Cells; 2001; 19(4):321-8. PubMed ID: 11463952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A differential sensitivity to recombinant human interferon-alpha 2a between normal and chronic myeloid leukaemic peripheral blood granulocyte-macrophage colony-forming units.
    Gronthos S; To LB; Haylock DN; Juttner CA
    Leuk Res; 1992; 16(2):153-8. PubMed ID: 1545568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential sequestration in vitro of BCR/ABL negative hematopoietic progenitor cells among cytokine nonresponsive CML marrow CD34+ cells.
    Veena P; Cornetta K; Davidson A; Agüero B; McMahel J; Traycoff CM; Srour EF
    Bone Marrow Transplant; 1997 Jun; 19(12):1213-21. PubMed ID: 9208115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct and overlapping direct effects of macrophage inflammatory protein-1 alpha and transforming growth factor beta on hematopoietic progenitor/stem cell growth.
    Keller JR; Bartelmez SH; Sitnicka E; Ruscetti FW; Ortiz M; Gooya JM; Jacobsen SE
    Blood; 1994 Oct; 84(7):2175-81. PubMed ID: 7919333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human chemokines: enhancement of specific activity and effects in vitro on normal and leukemic progenitors and a factor-dependent cell line and in vivo in mice.
    Broxmeyer HE; Cooper S; Hague N; Benninger L; Sarris A; Cornetta K; Vadhan-Raj S; Hendrie P; Mantel C
    Ann Hematol; 1995 Nov; 71(5):235-46. PubMed ID: 7492626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the inhibitory effect of AcSDKP, TNF-alpha, TGF-beta, and MIP-1 alpha on marrow-purified CD34+ progenitors.
    Bonnet D; Lemoine FM; Najman A; Guigon M
    Exp Hematol; 1995 Jun; 23(6):551-6. PubMed ID: 7539383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
    Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
    Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory activity of endogenous MIP-1 alpha in long-term cultures of human marrow.
    Cashman JD; Eaves AC; Wolpe S; Eaves CJ
    Prog Clin Biol Res; 1994; 389():261-8. PubMed ID: 7700910
    [No Abstract]   [Full Text] [Related]  

  • 19. The biology of normal and neoplastic stem cells in CML.
    Eaves C; Udomsakdi C; Cashman J; Barnett M; Eaves A
    Leuk Lymphoma; 1993; 11 Suppl 1():245-53. PubMed ID: 8251904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelosuppressive effects in vivo with very low dosages of monomeric recombinant murine macrophage inflammatory protein-1 alpha.
    Cooper S; Mantel C; Broxmeyer HE
    Exp Hematol; 1994 Feb; 22(2):186-93. PubMed ID: 8299739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.